Botanix Pharmaceuticals Ltd
News & analysis
Times are shown in GMT+10, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.Botanix Pharmaceuticals Ltd is a clinical stage medical dermatology company. It is engaged in developing medical dermatology products for treating skin diseases including acne, psoriasis and atopic dermatitis.
Latest BOT News